Page 1 2 ... 30 40 50 ... 200 ... NEXT>>
[ September 24, 2016 | Author: Admin | Views: 6209 | Weather: | Mood: normal]

Goldman Sachs analyst Noah Poponak and team like the defense sector but have some concerns about Lockheed Martin (LMT), particularly its valuation. They explain: Matt Cardy/Getty Images We continue to hold an Attractive sector view on Defense, where Lockheed is the bellwether and owns one of the Pentagons fastest growing programs in the F-35. However, the remainder of the portfolio is not particularly differentiated, there are earnings and cash flow headwinds compared to current consensus assumptions, and it is currently the most expensive Defense stock we cover. What we favor: 1. Defense budget at trough. Defense is right at the trough, with 2016 the first year of Department of Defense investment growth in 8 years, andLockheed Martin is the bellwether. 2.Joint Strike Fighter a substantial differentiator.Lockheed Martin is the prime on the F-35, which grows quickly through the end of the decade, allowing totalLockheed Martin revenue to grow faster than … Continue reading

[ September 24, 2016 | Author: Admin | Views: 37675 | Weather: | Mood: normal]

Eric Dy, co-founder and CEO of Bloom Technologies, accepting his award from Richard Branson after winning the Extreme Tech Challenge contest. Eric Dy is reeling from one of his most memorable experiences as an entrepreneur. Late Wednesday, Dy stood before Richard Branson for seven minutes and pitched his startup Bloom Technologies in the final round of the Extreme Tech Challenge contest. The San Francisco-based firm has developed a wearable sensor tied to an app that allows expectant moms track their pregnancy, such as frequency, duration, and intensity of contractions. Bloom Technologies was one of three finalists that traveled to Necker Island, Branson’s private Caribbean island, and pitch their business directly to the titan. Dy’s presentation landed Bloom Technologies the big win. 5 Best Electric Utility Stocks To Buy Right Now: Microsoft Corporation(MSFT) Microsoft Corporation develops, licenses, and supports a range of software products and services for various computing devices worldwide. … Continue reading

[ September 23, 2016 | Author: Admin | Views: 82399 | Weather: | Mood: normal]

A steady stream of multi-factor exchange traded funds have been coming to market for over a year now. Multi-factor ETFs offer investors exposure to several investment factors – the idea being that investors don't need to time when a certain factor will perform well and when others will fall out of favor. The Global X Scientific Beta US ETF (NYSE: SCIU), which is 14 months old, has proven, in real time, the advantages of the multi-factor structure. SCIU is part of a suite of Global X ETFs that follow “EDHEC-Risk Institute indices that target multiple factors, including low-volatility, momentum, size and value. The indices also combine the five models, including Maximum Deconcentration, Maximum Decorrelation, Efficient Minimum Volatility, Efficient Maximum Sharpe Ratio, and Diversified Risk Weighted,” according to ETF Trends. Best Oil Service Stocks To Watch For 2017: Move Inc.(MOVE) Move, Inc., together with its subsidiaries, operates an online network of … Continue reading

[ September 23, 2016 | Author: Admin | Views: 58488 | Weather: | Mood: normal]

Stocks finished mixed today as investors await the Federal Reserve’s decision on interest rateson Wednesday. Getty Images The S&P 500 dipped 0.1% to 2,019.64, while the Dow Jones Industrial Average rose 0.1% to 17,229.13. The Nasdaq Composite was little changed at 4,750.28. JPMorgan’sDavid Kelly doesn’t expect the Fed to raise interest rates at this week’s FOMC meeting despite the fact that the strength of the U.S. economy appears to justify it: The Federal Reserve meets this week and on Wednesday they will release their normal statement, accompanied by the release of a new set of FOMC economic forecasts and a press conference by Janet Yellen. In December, forecasts from the FOMC suggested four 25-basis point increases in the federal funds rate this year, a pace of increase that would have been very mild by historical standards. Since then, however, market volatility and statements by Fed officials in response have convinced … Continue reading

[ September 23, 2016 | Author: Admin | Views: 55964 | Weather: | Mood: normal]

With the Allergan (AGN)-Pfizer (PFE) merger scuttled by those pesky new Treausry rules on tax inversions, Allergan will have a lot of cash on hand to go shopping. Who will it buy? Citigroup’s Liav Abraham and Yigal Nochomovitz have ideas: Brendan McDermid /Reuters Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company to augment the breadth and depth its pipeline in its core therapeutic areas, including neurology, ophthalmology and dermatology, where innovation is rife and where consolidation of some of the smaller players in the space is likely, in our view. Stocks in our SMID coverage universe that could potentially constitute future acquisition targets forAllergan include Aclaris Therapeutics (ACRS) and Dermira (DERM) (both have mid- to late-stage dermatology assets in development). We note with interest the collaboration with Heptares announced yesterday evening for the development of several M1, M4 and dual M1/M4 … Continue reading